10x Genomics, Inc. (TXG) is listed on NASDAQ in Scientific Instrument Stocks. It is $61.55, -5.10%, with a $7.9B market cap. RSI is 62.0, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 62.0 Near Overbought
Market Cap $7.9B
Volume 1.8M
Fundamentals — 10-Q Q2 2026
Revenue $301.9M
Net Income $-31.4M
EPS $-0.24
Gross Margin 72.4%
Operating Margin -12.1%
Net Margin -10.4%
P/E Ratio -256.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer | Sell | 10,486 | $63.69 | $667,901 | 2026 Aug 26 |
| Saxonov Serge | Chief Executive Officer | Sell | 18,545 | $63.02 | $1.2M | 2026 Aug 24 |
| Taich Adam | Chief Financial Officer | Sell | 17,166 | $63.02 | $1.1M | 2026 Aug 24 |
| Hindson Benjamin J. | Insider | Sell | 13,818 | $63.02 | $870,860 | 2026 Aug 24 |
| Suliman Shehnaaz | Insider | Sell | 2,207 | $63.65 | $140,478 | 2026 Aug 24 |
| Teichmann Sarah A. | Insider | Sell | 7,551 | $57.25 | $432,279 | 2026 Aug 14 |
| Stuelpnagel John R | Insider | Sell | 20,000 | $57.75 | $1.2M | 2026 Aug 11 |
| Saxonov Serge | Chief Executive Officer | Sell | 30,000 | $34.44 | $1.0M | 2026 Jun 22 |
| Suliman Shehnaaz | Insider | Sell | 5,723 | $32.63 | $186,756 | 2026 Jun 16 |
| Saxonov Serge | Chief Executive Officer | Sell | 28,893 | $24.54 | $709,057 | 2026 May 26 |
| Hindson Benjamin J. | Insider | Sell | 11,595 | $24.44 | $283,399 | 2026 May 22 |
| Taich Adam | Chief Financial Officer | Sell | 15,098 | $24.44 | $369,018 | 2026 May 22 |
| Saxonov Serge | Chief Executive Officer | Sell | 5,000 | $24.56 | $122,784 | 2026 Apr 14 |
| Saxonov Serge | Chief Executive Officer | Sell | 15,000 | $19.26 | $288,909 | 2026 Mar 24 |
| Saxonov Serge | Chief Executive Officer | Sell | 16,152 | $22.73 | $367,097 | 2026 Mar 2 |
| Teichmann Sarah A. | Insider | Sell | 7,579 | $19.41 | $147,108 | 2026 Feb 25 |
| Saxonov Serge | Chief Executive Officer | Sell | 9,632 | $18.58 | $178,928 | 2026 Feb 23 |
| Taich Adam | Chief Financial Officer | Sell | 8,968 | $18.58 | $166,593 | 2026 Feb 23 |
| Hindson Benjamin J. | Insider | Sell | 7,826 | $18.58 | $145,379 | 2026 Feb 23 |
| Taich Adam | Chief Financial Officer | Sell | 11,888 | $19.00 | $225,872 | 2025 Nov 24 |
Other Scientific Instrument Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $622.12 | 68.8 | $230.0B |
| | $354.68 | 46.6 | $55.5B |
| | $216.06 | 59.5 | $151.9B |
| | $57.07 | 49.6 | $8.7B |
| | $80.75 | 41.9 | $2.6B |
| | $61.01 | 62.6 | $14.2B |
| | $236.24 | 41.7 | $54.2B |
| | $59.69 | 45.4 | $18.2B |
Take TXG further
- Browse Scientific Instrument Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TXG in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when 10x Genomics, Inc. next reports.
Set alerts on TXG
Get notified when 10x Genomics, Inc. hits your price targets or technical conditions are met.
Get Started Free